DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$1.09
0.00 (0.00%)
▲
5d:
+0.0%
30d:
-10.66%
90d:
-62.02%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -10.0% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: DH trading at deep discount. Market pricing in -10.0% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $1.09, which is considered slightly low relative to its 30-day fair value range of $1.07 to $1.28. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.8) compared to its historical average (8.0). Remarkably, the market is currently pricing in an annual earnings decline of 10.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $1.02, while resistance sits at $1.24.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.55 (+133.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $1.02, while resistance sits at $1.24.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.55 (+133.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.07 -
$1.28
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 133.9% below Wall St target ($2.55)
Fair Price Analysis
30-Day Fair Range
$1.07 -
$1.28
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.24
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.85
Wall Street Target
$2.55
(+133.9%)
Revenue Growth (YoY)
-1.2%
Profit Margin
-57.5%
Valuation Discount vs History
-10.0% cheaper
PE vs Historical
5.9 vs 8.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.0%
(market-implied from PE analysis)
1-Year Target
$0.98
(-10%)
2-Year Target
$0.88
(-19%)
3-Year Target
$0.79
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→8)
$1.09
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.5%)
$5.77
(+429%)
Base:
(SPY PE: 5.9, Growth: 11.5%)
$1.51
(+39%)
Bear:
(PE: 5.0, Growth: 11.5%)
$1.28
(+18%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.9 to 8.0
Stabilization Target:
$1.49
(+36.7%)
PE Expansion Potential:
+36.7%
Share & Embed Analysis
Last updated: April 02, 2026 2:25 PM ET
Data refreshes hourly during market hours. Next update: 3:25 PM
Data refreshes hourly during market hours. Next update: 3:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 60 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 62 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 67 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 52 HOLD |
